OIT oral immunotherapy a b s t r a c t
Introduction
An increased prevalence of food allergies has been reported in Western countries as well as in Asia, 1 and the health and economic burden associated with such allergies has become significant.
2,3
Oral immunotherapy (OIT), in which the immune system is desensitized to foods that cause allergic reactions, 4 has attracted attention as a new treatment for food allergies. 
Methods

First survey
We collected data via two rounds of surveys, following the same methods used in 2011. 19 In the first survey, we mailed questionnaires to training and teaching facilities of the Japan Pediatric Society from mid-July to mid-August 2015. The questionnaires requested information on the implementation of OIT by the end of March 2015, and consent to participate in the second survey.
Second survey
Between mid-August and the end of September 2015, we mailed questionnaires to the facilities that agreed to participate in the second survey. Clinical information of individual patients was obtained from the facilities that responded to a second survey. Questionnaire items are shown in Table 1 .
Definition of OIT
There were no standardized protocols for OIT. Previous studies included widely heterogeneous groups of patients. 5e10,12,13 OIT was defined in this study as a treatment for patients (1) who hardly expect to acquire tolerance to foods soon, (2) for whom the threshold dose that induced allergic symptoms was determined by oral food challenge prior to OIT, and (3) who underwent OIT under a physician's supervision. Furthermore, we defined inpatient OIT as treatments provided while the patient was hospitalized, although the patient may have been subsequently followed up in outpatient clinics. In contrast, outpatient OIT was defined as treatments and follow-up provided without hospitalization.
Statistical analysis
The statistical evaluation was performed in SPSS 24.0 (IBM Corporation, Armonk, NY, USA). To analyze differences between 2 groups, we used Fisher's exact test for statistical comparison, and we considered p < 0.05 statistically significant.
Ethical considerations
This study was approved by the Ethics Committee of Sagamihara National Hospital in Kanagawa, Japan (No.150706). Surveys were performed in accordance with the principles embodied in the Declaration of Helsinki of 1965 (as revised in Brazil 2013). This questionnaire did not include personal details of the patients, and clinical data were de-identified and handled as linked anonymized data.
Results
Response rate
We obtained information from 360 (69%) of the 524 training and teaching facilities surveyed (Fig. 1) . Among them, 102 facilities (28%) provided OIT, and 78 facilities agreed to participate in the second survey ( Supplementary Fig. 1 ). Among the facilities that agreed to participate in a second survey, 27 (79%) of 34 inpatient OIT facilities responded, and 67 (72%) of 93 outpatient OIT facilities responded.
Approval from institutional review boards and informed consent
OIT was provided with approval from institutional review boards in 89% of the facilities providing inpatient OIT, and 31% of those providing outpatient OIT (Fig. 2) . Of these facilities, 100% and 42%, respectively, obtained informed consent.
Applicable age and exclusion criteria for OIT, as determined by the facilities For inclusion criteria, 22 inpatient OIT facilities (81%) and 35 outpatient OIT facilities (52%) included a lower or upper age limit ( Supplementary Fig. 2 ). Regarding the lower age limits, 1% of inpatient OIT facilities were performing OIT for patients under 3 years of age, whereas the respective proportion was 74% for outpatient OIT facilities. Regarding the upper age limits, 0% of inpatient OIT facilities and 10% of outpatient OIT facilities had upper age limits. Ethical approval from an institutional review board OFC, oral food challenge; OIT, oral immunotherapy. Fig. 1 . Number of facilities that provide oral immunotherapy. This chart is based on the 360 facilities that responded to the first round of survey.
